FDA Drug Application (202103) for DASATINIB by APOTEX INC

Back to FDA Applications sponsored by APOTEX INC

Application Number202103
Product Number001
FormTABLET;ORAL
Dosage20MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDASATINIB
Active IngredientDASATINIB

Active IngredientCount
List of drugs with Active Ingredient DASATINIB2


Back to FDA Applications sponsored by APOTEX INC